About Biopta
Biopta is a company based in Godalming (United Kingdom) founded in 2002 was acquired by ReproCELL in November 2015.. Biopta has raised $1.57 million across 3 funding rounds from investors including Scottish Enterprise, ReproCELL and Braveheart Investment Group. Biopta operates in a competitive market with competitors including Anabios, Clyde Biosciences, Metrion Biosciences, Quiver Bioscience and Zen-Bio, among others.
- Headquarter Godalming, United Kingdom
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.57 M (USD)
in 3 rounds
-
Latest Funding Round
$425.8 K (USD), Seed
Nov 04, 2010
-
Investors
Scottish Enterprise
& 3 more
-
Employee Count
Employee Count
-
Acquired by
ReproCELL
(Nov 25, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Biopta
Biopta has successfully raised a total of $1.57M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $425.8 thousand completed in November 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Seed — $425,797
-
First Round
First Round
(08 Dec 2008)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2010 | Amount | Seed - Biopta | Valuation |
investors |
|
| Apr, 2010 | Amount | Seed - Biopta | Valuation |
investors |
|
| Dec, 2008 | Amount | Seed - Biopta | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biopta
Biopta has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Scottish Enterprise, ReproCELL and Braveheart Investment Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investment firm
|
Founded Year | Domain | Location | |
|
Early-stage Scottish companies are supported with investment and expertise.
|
Founded Year | Domain | Location | |
|
Business development and leadership training programs are offered to companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biopta
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Biopta
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biopta Comparisons
Competitors of Biopta
Biopta operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Anabios, Clyde Biosciences, Metrion Biosciences, Quiver Bioscience and Zen-Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Ex-vivo human tissue studies are performed for preclinical drug discovery.
|
|
| domain | founded_year | HQ Location |
Cardiac safety testing is conducted using iPS-derived heart cells.
|
|
| domain | founded_year | HQ Location |
Ion channel screening and cardiac safety profiling services are provided.
|
|
| domain | founded_year | HQ Location |
Developer of transformational medicines for neurological disorders
|
|
| domain | founded_year | HQ Location |
Cell-based solutions are provided to accelerate therapy discovery and development.
|
|
| domain | founded_year | HQ Location |
Multiplexed immunoassays for protein biomarkers are developed via proprietary platform.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Biopta
When was Biopta founded?
Biopta was founded in 2002 and raised its 1st funding round 6 years after it was founded.
Where is Biopta located?
Biopta is headquartered in Godalming, United Kingdom.
Is Biopta a funded company?
Biopta is a funded company, having raised a total of $1.57M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1.14M, raised on Dec 08, 2008.
What does Biopta do?
Biopta Ltd is a contract research company focussed on the use of fresh functional human tissues in drug development. Biopta was spun out of Glasgow Caledonian University by its co-founders, Dr David Bunton and Professor Chris Hillier, with the aim of addressing the high failure rate of drugs during clinical trials through the use of ethically-sourced human tissues. Bioptas expertise in all areas of human tissue research including sourcing, handling and experimenting on human tissue. Biopta is able to provide early indications of drug safety, efficacy and absorption. Our human ex vivo pharmacology models bridge the gap between animal in vivo data and the clinic. In Nov 2015, the company was acquired by ReproCELL.
Who are the top competitors of Biopta?
Biopta's top competitors include Metrion Biosciences, Quiver Bioscience and Anabios.
Who are Biopta's investors?
Biopta has 4 investors. Key investors include Scottish Enterprise, ReproCELL, Braveheart Investment Group, and TRICAPITAL Angels.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.